Literature DB >> 9364393

Anterior cruciate ligament tears in children: an analysis of operative versus nonoperative treatment.

A E Pressman1, R M Letts, J G Jarvis.   

Abstract

A 12-year retrospective analysis of 42 children with arthroscopically confirmed anterior cruciate ligament disruption was undertaken to determine (a) the subjective efficacy of treatment, (b) the clinical and biomechanical results of operative and nonoperative management, and (c) the most appropriate long-term outcome measurements. Patients were followed up for a mean of 5.3 years from the time of initial treatment and were between the ages of 5 and 17 years (mean, 14.4) at the time of treatment. The children were treated nonoperatively by primary ligament repair or by intraarticular anterior cruciate ligament reconstruction. In the child, a complete tear of the anterior cruciate ligament was best managed by intraarticular surgical reconstruction. This was confirmed by clinical examination (p < 0.01), by a composite knee score involving a clinical examination and patient questionnaire (p < 0.0005), and by testing with the KT-1000 arthrometer. No significant differences in outcome could be attributed to the patient age or the maturity of the growth plates. In the active child, anterior cruciate reconstruction for complete tears resulted in a more stable and functional knee.

Entities:  

Mesh:

Year:  1997        PMID: 9364393

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  26 in total

1.  Good surgical outcome of transphyseal ACL reconstruction in skeletally immature patients using four-strand hamstring graft.

Authors:  Aurélien Courvoisier; Mathieu Grimaldi; Stéphane Plaweski
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-10-02       Impact factor: 4.342

2.  All-epiphyseal anterior cruciate ligament reconstruction in skeletally immature patients.

Authors:  J Todd R Lawrence; Andrea L Bowers; Jonathan Belding; Stephanie R Cody; Theodore J Ganley
Journal:  Clin Orthop Relat Res       Date:  2010-02-20       Impact factor: 4.176

3.  The functional outcome of total tears of the anterior cruciate ligament (ACL) in the skeletally immature patient.

Authors:  Stephanie Arbes; Christoph Resinger; Vilmos Vécsei; Thomas Nau
Journal:  Int Orthop       Date:  2006-09-01       Impact factor: 3.075

Review 4.  Stump entrapment of the anterior cruciate ligament in late childhood and adolescence.

Authors:  Arthur B Meyers; Tal Laor; Andrew M Zbojniewicz
Journal:  Pediatr Radiol       Date:  2011-01-18

5.  No bone tunnel enlargement in patients with open growth plates after transphyseal ACL reconstruction.

Authors:  S Kopf; J-P Schenkengel; G Wieners; C Stärke; R Becker
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-02-03       Impact factor: 4.342

6.  High satisfaction yet decreased activity 4 years after transphyseal ACL reconstruction.

Authors:  Gregory A Schmale; Christopher Kweon; Roger V Larson; Viviana Bompadre
Journal:  Clin Orthop Relat Res       Date:  2014-03-15       Impact factor: 4.176

Review 7.  [Rupture of the anterior cruciate ligament in growing children: surgical or conservative treatment? A systematic review].

Authors:  A Preiss; T Brodhun; I Stietencron; K-H Frosch
Journal:  Unfallchirurg       Date:  2012-09       Impact factor: 1.000

8.  [Anterior cruciate ligament reconstruction with hamstring tendons in the young].

Authors:  C Sobau; A Ellermann
Journal:  Unfallchirurg       Date:  2004-08       Impact factor: 1.000

9.  Performance-based functional outcome for children 12 years or younger following anterior cruciate ligament injury: a two to nine-year follow-up study.

Authors:  Håvard Moksnes; Lars Engebretsen; May Arna Risberg
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2007-12-22       Impact factor: 4.342

10.  Femoral mechanical-biological graft fixation in ACL reconstruction in young patients.

Authors:  João Ellera Gomes; Cássio Alves Konrath
Journal:  Clinics (Sao Paulo)       Date:  2010-03       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.